Folic acid supplementation among diabetic, overweight, or obese women of childbearing age

JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

Volumn 36, Issue 4, 2007, Pages 335-341

  Case, Amy P ^a   Ramadhani, Tunu A ^a   Canfield, Mark A ^a   Beverly, Lara ^b   Wood, Rebecca ^a  

^a TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Diabetes; Folic acid; Obesity

Indexed keywords

EID: 34347379709     PISSN: 08842175     EISSN: 15526909     Source Type: Journal    
DOI: 10.1111/j.1552-6909.2007.00163.x     Document Type: Article

References (38)

1. Aberg, A., Westbom, L., & Kallen, B. (2001). Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Human Development, 61, 85-95.
2. Anderson, J., Waller, D. K., Canfield, M. A., Shaw, G. M., Watkins, M. L., & Werler, M. M. (2005). Maternal obesity, gestational diabetes, and central nervous system birth defects. Epidemiology, 16, 1.
3. Cabrera, R. M., Hill, D. S., Etheredge, A. J., & Finnell, R. H. 2004. Investigations into the etiology of neural tube defects. Birth Defects Research (Part C), 72, 330-334.
4. Canfield, M. A., Annegers, J. F., Brender, J. D., Cooper, S. P., & Greenberg F. (1996b). Hispanic origin and neural tube defects in Houston/ Harris County, Texas. II. Risk factors. American Journal of Epidemiology, 143, 12-24.
5. Canfield, M. A., Annegers, J. F., Brender, J. D., Cooper, S. P., & Greenberg F. (1996a). Hispanic origin and neural tube defects in Houston/ Harris County, Texas. I. Descriptive Epidemiology. American Journal of Epidemiology, 143, 1-11.
6. Canfield, M. A., Przybyla, S. M., Case, A. P., Ramadhani, T., Suarez, L., & Dyer, J. (2006). Folic acid awareness and supplementation among Texas women of childbearing age. Preventive Medicine, 43, 27-30.
7. Carmichael, S. L., Shaw, G. M., Selvin, S., & Schaffer, D. M. (2003). Diet quality and risk of neural tube defects. Medical Hypotheses, 60, 351-355.
8. Centers for Disease Control and Prevention. (1992). Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morbidity and Mortality Weekly Report, 41, 1-8.
9. Centers for Disease Control and Prevention. (1997). Knowledge and use of folic acid by women of childbearing age -United States. Morbidity and Mortality Weekly Report, 46, 721-723.
10. Centers for Disease Control and Prevention. (2005). Use of dietary supplements containing folic acid among women of childbearing age-United States, 2005. Morbidity and Mortality Weekly Report, 54, 955-958.
11. Detrait, E. R., George, T. M., Etchevers, H. C., Gilbert, J. R., Vekemans, M., & Speer, M. C. (2005). Human neural tube defects: Developmental biology, epidemiology, and genetics. Neurotoxicology and Teratology, 27, 515-524.
12. Flegal, K. M., Gillum, R. F., Sempos, C. T. (2005). Epidemiologic aspects of overweight and obesity in the United States. Physiology and Behavior, 86, 599-602.
13. Gillum, R. F., & Sempos, C. T. (2005). Ethnic variation in validity of classification of overweight and obesity using self-reported weight and height in American women and men: The Third National Health and Nutrition Examination Survey. Nutrition Journal, 4, 27.
14. Goldberg, B. B., Alvarado, S., Chavez, C., Chen, B. H., Dick, L. M., Felix, R. J., et al. (2006). Prevalence of periconceptional folic acid use and perceived barriers to the postgestation continuance of supplemental folic acid: Survey results from a Teratogen Information Service. Birth Defects Research, Part A, Clinical and Molecular Teratology, 76, 193-199.
15. Harris, J. A., & Shaw, G. M. (1995). Neural tube defects-Why are rates high among populations of Mexican descent? Environmental Health Perspectives, 103, 136-164.
16. Hendricks, K. A., Nuno, O. M., Suarez, L., & Larsen R. (2001). Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology, 12, 630-635.
17. Hendricks, K. A., Simpson, J. S., & Larsen, R. D. (1999). Neural tube defects along the Texas-Mexico border, 1993-1995. American Journal of Epidemiology, 149, 1119-1127.
18. Kallen, K. (1998). Maternal smoking, body mass index, and neural tube defects. American Journal of Epidemiology, 147, 1103-1111.
19. Kaufman, B. A. (2004). Neural tube defects. Pediatric Clinics of North America, 51, 389-419.
20. Little, L., & Elwood, J. M. (1991). Epidemiology of neural tube defects. Reproductive and perinatal epidemiology. M. Kiley (Ed.). Boston: CRC Press.
21. Mojtabai, R. (2004). Body mass index and serum folate in childbearing age women. European Journal of Epidemiology, 19, 1029-1036.
22. Myrianthopoulos, N. C., & Melnick, M. (1987). Studies in neural tube defects. I. Epidemiologic and etiologic aspects. American Journal of Medical Genetics, 26, 783-796.
23. National Academy of Sciences. (1990). Nutrition during pregnancy. Institute of Medicine, Food and Nutrition Board. Washington, DC: National Academy Press.
24. Nelson, D. E., Holtzman, D., Bolen, J., Stanwyck, C. A., & Mack, K. A. (2001). Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Social and Preventive Medicine, 46 (Suppl 1): S03-S42.
25. Nelson, D. E., Powell-Griner, E., Town, M., & Kovar, M. G. (2003). A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System. American Journal of Public Health, 93, 1335-1341.
26. O'Rourke, K. M., Roddy, M. E., Williams, D., & Mena K. (2006). Predictors of early postpartum vitamin use among women of Mexican origin: Implications for healthcare provider recommendations. Ethnicity and Disease, 16, 194-200.
27. Ray, J. G., Wyatt, P. R., Vermeulen, M. J., Meier, C., & Cole, D. E. (2005). Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortification. Obstetrics and Gynecology, 105, 261-265.
28. Rosenberg, T. J., Garbers, S., Lipkind, H., & Chiasson, M. A. (2005). Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: Differences among 4 racial/ethnic groups. American Journal of Public Health, 95, 1545-1551.
29. Shaw, G. M., Jensvold, N. G., Wasserman, C. R., & Lammer, E. J. (1994). Epidemiologic characteristics of phenotypically distinct neural tube defects among 0.7 million California births, 1983-87. Teratology, 49, 143-149.
30. Shaw, G. M., Todoroff, K., Finnell, R. H., & Lammer, E. J. (2000). Spina bifida phenotypes in infants or fetuses of obese mothers. Teratology, 61, 376-381.
31. Shaw, G. M., Velie, E. M., & Schaffer, D. (1996). Risk of neural tube defect-affected pregnancies among obese women. Journal of the American Medical Association, 275, 1093-1096.
32. Texas Department of State Health Services. (2006). Texas birth defects registry report of birth defects among 1999-2003 deliveries (DSHS Publication No. 58-12309). Austin, TX: Author.
33. Waller, D. K., Mills, J. L., Simpson, J. L., Cunningham, G. C., Conley, M. R., Lassman, M. R., et al. (1994). Are obese women at higher risk for producing malformed offspring? American Journal of Obstetrics and Gynecology, 170, 541-548.
34. Watkins, M., Rasmussen, S., Honein, M., Botto, L., & Moore C. (2003). Maternal obesity and risk for birth defects. Pediatrics, 111, 1152-1158.
35. Wentzel, P., & Eriksson, U. J. (2005). A diabetes-like environment increases malformation rate and diminishes prostaglandin E (2) in rat embryos: Reversal by administration of vitamin E and folic acid. Birth Defects Research. Part A, Clinical and Molecular Teratology, 73, 506-511.
36. Wentzel, P., Gareskog, M., & Eriksson, U. J. (2005). Folic acid supplementation diminishes diabetes- and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes, 54, 546-553.
37. Werler, M. M., Louik, C., Shapiro, S., & Mitchell, A. A. (1996). Prepregnant weight in relation to risk of neural tube defects. Journal of the American Medical Association, 275, 1089-1092.
38. Wilson, R. D., Davies, G., Desilets, V., Reid, G. J., Summers, A., Wyatt, P., et al. (2003). Genetics Committee and Executive and Council of the Society of Obstetricians and Gynaecologists of Canada. The use of folic acid for the prevention of neural tube defects and other congenital anomalies. Journal of Obstetrics and Gynaecology Canada, 25, 959-973.